“Silicon nitride is among the most advanced ceramic materials”, said Dr. Sonny Bal, chairman and CEO of SINTX Technologies, “with applications across many industries. In addition to being approved for highly-demanding medical device applications, our formulation of silicon nitride has been characterized, validated, and tested extensively through a robust R&D program, and is fully competitive with industrial formulations required, for example, by the aerospace and defense industries. With the addition of Don, SINTX is well-positioned to focus on markets outside medical devices.”
“As SINTX explores new sources of OEM revenue and new partnerships inside and outside of health care, Don’s extensive background and experience in technical ceramics and business development are particularly relevant. In addition, Don has a proven track record of securing federal, state, and local funds in support of technology development; these skills will help SINTX continue a strategic pivot toward positioning its silicon nitride and related ceramic technologies for a broad range of medical and non-medical applications,” added Dr. Bal.
“I am thrilled to be part of the SINTX team”, said Bray. “My entire career has been spent in the advanced materials industry and I look forward to continuing that work in helping SINTX grow. They have a strong technology and manufacturing suite with many potential applications.”
SINTX Technologies is an OEM ceramics company that develops and commercializes silicon nitride for biomedical applications, such as spine and dental implants. The core strength of SINTX Technologies is the research and development of medical-grade silicon nitride ceramics for external partners. The company presently manufactures silicon nitride spinal implants in its ISO 13485 certified manufacturing facility for CTL-Amedica, the exclusive retail channel for silicon nitride spinal implants.